EUS-guided fistulization AXIOS
DeviceBy using a convex type ultrasonic endoscope to form a fistula by gastrointestinal puncture, to perform various drainage.
NCT Number: NCT03797209
To detect information of Adverse Events and Device Malfunctions under real world medical condition in Japan.
Looking for future studies?
Notify MeAll sexes
Observational
Aichi Medical University Hospital, Nagakute-Shi, Aichi-ken, Japan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
By using a convex type ultrasonic endoscope to form a fistula by gastrointestinal puncture, to perform various drainage.
Time frame: From implant procedure to 7 days after removal
Time frame: During implant procedure
AXIOS stent is placed in an appropriate position using the delivery system.
Time frame: From implant procedure to removal (a maximum of 60 days)
AXIOS stent stays at the position where it was implanted during the implant procedure.
Time frame: From implant procedure to removal (a maximum of 60 days)
The lumen of AXIOS stent is patent, and it can be used for drainage etc.
Time frame: From implant procedure to final observation (a maximum of 60 days)
Time frame: Removal procedure (a maximum of 60 days after implant procedure)
AXIOS stent can be removed using standard endoscopic snares or forceps.
Boston Scientific Japan K.K.
Industry
A Post Market Survey to Detect Information of Adverse Events and Device Malfunctions of AXIOS Stent and Electrocautery Enhanced Delivery System Under Real World Medical Condition in Japan
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02845258
Cysts, Digestive System Diseases
Gothenburg, Sweden
View Trial DetailsNCT03147768
Adenocarcinoma, Adenoma
Houston, Texas, United States
View Trial DetailsNCT03002051
Acute Cholecystitis, Biliary Obstruction
Hong Kong, China
View Trial DetailsNCT02730663
Cysts, Digestive System Diseases
Bucheon-si, Gyeonggi-do, South Korea
View Trial Details